Identification of a novel keyhole phenotype in double-disk diffusion assays of clindamycin-resistant erythromycin-sensitive strains of Streptococcus agalactiae

Microbial Drug Resistance

Volumn 17, Issue 1, 2011, Pages 121-124

  Srinivasan, Usha ^a   Miller, Brady ^a   Debusscher, Joan ^a   Marrs, Carl F ^a   Zhang, Lixin ^a   Seo, Yong Soo ^b   Oh, Kwan Young ^c   Kim, Moon Young ^d   Yoon, Hye Ryung ^e   Ki, Moran ^f   Foxman, Betsy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Eulji General Hospital   (South Korea)

^c Eulji University   (South Korea)

^d Kwandong University College of Medicine   (South Korea)

^e Seoul Medical Science Institute   (South Korea)

^f Eulji University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CLINDAMYCIN; ERM(B) PROTEIN; ERYTHROMYCIN; LNU(B) PROTEIN; MEF(A) PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BROTH DILUTION; DISK DIFFUSION; DNA HYBRIDIZATION; DNA SEQUENCE; DRUG SENSITIVITY; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTH KOREA; STREPTOCOCCUS AGALACTIAE;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; OPEN READING FRAMES; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANCY; REPUBLIC OF KOREA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

STREPTOCOCCUS AGALACTIAE;

EID: 79952423612     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2010.0040     Document Type: Article

References (9)

1. Andrews, J. I., D. J. Diekema, S. K. Hunter, et al. 2000. Group B Streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am. J. Obstet. Gynecol. 183:859-862.
2. CLSI/NCCLS. 2005. Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard, 15th Informational Supplement, M100-S15. CLSI/NCCLS, Wayne, PA.
3. Farrow, K. A., D. Lyras, G. Polekhina, et al. 2002. Identification of essential residues in the Erm (B) rRNA methyltransferase of Clostridium perfringens. Antimicrob. Agents Chemother. 46:1253-1261. (Pubitemid 34415299)
4. Gibbs, R. S., S. Schrag, and A. Schuchat. 2004. Perinatal infections due to Group B Streptococci. Obstet. Gynecol. 104:1062-1076. (Pubitemid 40458775)
5. Gygax, S. E., J. A. Schuyler, L. E. Kimmel, et al. 2006. Erythromycin and clindamycin resistance in Group B Streptococcal clinical isolates. Antimicrob. Agents Chemother. 50:1875-1877.
6. Levin, T. P., B. Suh, P. Axelrod, et al. 2005. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob. Agents Chemother. 49:1222-1224. (Pubitemid 40327755)
7. Seo, Y. S., U. Srinivasan, K. Y. Oh, et al. 2010. Changing molecular epidemiology of Group B Streptococcus in Korea. J. Korean Med. Sci. 25:817-823.
8. Varaldo, P. E., M. P. Montanari, and E. Giovanetti. 2009. Genetic elements responsible for erythromycin resistance in Streptococci. Antimicrob. Agents Chemother. 53:343-353.
9. Zhang, L., U. Reddi, U. Srinivasan, et al. 2008. Combining microarray technology and molecular epidemiology to identify genes associated with invasive Group B Streptococcus. Interdiscip. Perspect. Infect. Dis., Article ID 31 4762. Epub 2008 Feb. 25.